2. Receivables

Receivables consist of the following:


	September 30,		December 31,		September 30,
	2015		2014		2014
Trade accounts receivable	$	782	$	583	$	887
Less: allowances for doubtful accounts and discounts		29		34		37
Net trade receivables		753		549		850
Other receivables		355		195		192
	$	1,108	$	744	$	1,042

In conjunction with the Vitro Acquisition, the Company remitted approximately $147 million related to value added taxes owed as a result of certain internal restructuring transactions undertaken by Vitro, S.A.B. de C.V. related to the closing of the Vitro Acquisition. This amount is included in “Other receivables” above and is expected to be refunded to the Company in approximately twelve months.

The Company uses various factoring programs to sell certain receivables to financial institutions as part of managing its cash flows. The amount of receivables sold by the Company was $336 million, $276 million, and $209 million at September 30, 2015, December 31, 2014, and September 30, 2014, respectively. Any continuing involvement with the sold receivables is immaterial.